Puma Biotechnology, Inc. share price logo

Puma Biotechnology, Inc. Share Price

NASDAQ: PBYI

Small Cap

$6.50

+0.24

(+3.83%)

Live

as on

Puma Biotechnology, Inc. Stock Performance

as on March 26, 2026 at 3:11 am IST

  • Day's Low

    Day's High

    $6.37
    $6.52
    downward going graph

    2.00%

    Downside

    0.31%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.58
    $7.68
    downward going graph

    60.38%

    Downside

    18.15%

    Upside

    downward going graph

Puma Biotechnology, Inc. share price movements today

Previous Close
$6.26
Open
$6.39
Volume
303.2K
Day's Low - High
$6.37 - $6.52
52 Week Low - High
$2.58 - $7.68

Puma Biotechnology, Inc. Historical Returns

1 Month Return
-18.49 %
3 Month Return
+ 5.03 %
1 Year Return
+ 92.62 %
3 Year Return
+ 183.26 %
5 Year Return
-38.08 %

Puma Biotechnology, Inc. Stock Fundamentals & Key Indicators

Check Puma Biotechnology, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$318.0M

EPS (TTM)

0.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.34%

PE Ratio (TTM)

10.25

Industry PE ratio

-4.703771043771043

PEG Ratio

0.03

EBITDA

47.4M

Revenue (TTM)

228.4M

Profit Margin

13.62%

Return On Equity TTM

27.97%

Puma Biotechnology, Inc. Stock Valuation

Track how Puma Biotechnology, Inc. P/E has moved over time to understand its valuation trends.

Puma Biotechnology, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-62.40x)

June 30, 2023

Industry (-4.70x)

March 25, 2026

Today (10.25x)

March 25, 2026

Highest (42.57x)

September 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 10.25x

Puma Biotechnology, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Puma Biotechnology, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Puma Biotechnology, Inc. image
Puma Biotechnology, Inc.
SELL$318.0M-38.08%10.2513.62%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$40.7B127.78%131.618.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$114.6B111.25%29.4232.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA111.235.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.9B60.03%17.7631.41%

Stock Returns calculator for Puma Biotechnology, Inc. Stock including INR - Dollar returns

The Puma Biotechnology, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Puma Biotechnology, Inc. investment value today

Current value as on today

₹2,09,961

Returns

₹1,09,961

(+109.96%)

Returns from Puma Biotechnology, Inc. Stock

₹1,00,000 (+100%)

Dollar Returns*

₹9,961 (+9.96%)

Analyst Recommendation on Puma Biotechnology, Inc. Stock

Based on 8 analysts

SELL

12.50%

Buy

37.50%

Hold

50.00%

Sell

Based on 8 analysts, 50% of analysts recommend a 'SELL' rating for Puma Biotechnology, Inc.. Average target price of $5

Puma Biotechnology, Inc. Share Price Target

Get share price movements and forecasts by analysts on Puma Biotechnology, Inc..

What analysts predicted

-30%DOWNSIDE

Target Price

$5

Current Price

$6.5

Analyzed by

8 Analysts

Target

$5.00

Puma Biotechnology, Inc. target price $5, a slight downside of -30% compared to current price of $6.5. According to 8 analysts rating.

Puma Biotechnology, Inc. Stock’s Investor Sentiment and Interest

Search interest for Puma Biotechnology, Inc. Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-43% versus previous 30 day period

Puma Biotechnology, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
56
72
43
47
80
59
46
52
54
75
Gross Profit
42
47
33
36
51
45
35
40
42
52
Operating Income
8
14
-2
-2
22
13
3
6
9
17
EBITDA
11
18
1
2
26
17
8
10
13
26
Interest Expense
3
3
3
3
3
2
2
1
1
1
Depreciation
2
2
2
2
2
2
2
2
2
2
Income Before Tax
6
12
-4
-4
20
12
3
6
9
17
Income Tax Expense
0
0
0
0
0
-7
0
0
0
3
Net Income
5
12
-4
-4
20
19
2
5
8
13
Net Profit Margin
10.33%
17.00%
-11.00%
-9.62%
25.23%
32.68%
6.46%
11.17%
16.23%
17.75%

Puma Biotechnology, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
27
251
272
225
253
228
235
230
228
Gross Profit
-1
22
216
235
185
189
172
172
166
170
Operating Income
-276
-292
-94
-75
-30
1
23
32
30
37
EBITDA
-275
-288
-95
-52
-35
-4
21
47
48
53
Interest Expense
0
0
11
15
14
12
11
13
12
6
Depreciation
-
2
7
8
10
10
8
10
11
10
Income Before Tax
-276
-292
-113
-75
-59
-28
0
22
24
35
Income Tax Expense
-2
-2
-7
0
0
0
0
1
-6
4
Net Income
-276
-292
-113
-75
-59
-29
0
21
30
31
Net Profit Margin
0.00%
-1054.15%
-45.26%
-27.77%
-26.65%
-11.51%
0.00%
9.16%
13.14%
13.62%

Puma Biotechnology, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
12
-4
-4
20
19
2
5
8
11
Operating Cash Flow
10
11
1
11
15
3
14
9
14
Investing Cash Flow
-8
-19
0
0
-2
1
-11
0
-26
Financing Cash Flow
-
-
-11
-11
-11
-11
-11
-11
-11
Change in Cash
2
-7
-9
0
1
-6
-8
-1
-23

Puma Biotechnology, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-291
-113
-75
-59
-29
0
21
30
31
Operating Cash Flow
-172
-24
22
0
20
-15
27
38
41
Investing Cash Flow
-15
-57
5
23
-10
7
-19
-20
-36
Financing Cash Flow
75
108
-67
0
-31
12
2
-33
-45
Change in Cash
-112
26
-39
24
-22
3
7
-15
-39

Global Institutional Holdings in Puma Biotechnology, Inc.

Funds
Holdings
Charles Schwab Investment Management Inc
0.25%
Vanguard Group Inc
7.46%
Bank of New York Mellon Corp
0.68%
American Century Companies Inc
3.24%
Acadian Asset Management LLC
4.04%
See all

Insights on Puma Biotechnology, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 2.97M → 13.4M (in $), with an average increase of 39.0% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PBYI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, PBYI stock has moved up by 92.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PBYI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 46.00M → 75.5M (in $), with an average increase of 14.6% per quarter

About Puma Biotechnology, Inc.

we focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
OrganisationPuma Biotechnology, Inc.
Headquarters10880 Wilshire Boulevard, Los Angeles, CA, United States, 90024
IndustryHealth Technology
CEOMr. Alan H. Auerbach
E-voting on sharesClick here to vote

Key Management of Puma Biotechnology, Inc.

Name

Title

Mr. Mariann Ohanesian

Senior Director of Investor Relations

Ms. Heather Blaber

Senior Vice President of Marketing

Mr. Roger L. Storms

Senior Vice President of Sales

Mr. Alan H. Auerbach

Founder, Chairman, President, CEO & Secretary

Mr. Maximo F. Nougues

CFO & Principal Accounting Officer

Mr. Douglas Hunt B.Sc., FRAPS

Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer

FAQs

What is Puma Biotechnology, Inc. share price today?

Puma Biotechnology, Inc. share price today is $6.5 as on . Puma Biotechnology, Inc. share today touched a day high of $6.52 and a low of $6.37.

What is the 52 week high and 52 week low for Puma Biotechnology, Inc. share?

Puma Biotechnology, Inc. share touched a 52 week high of $7.68 on and a 52 week low of $2.58 on . Puma Biotechnology, Inc. stock price today i.e. is trending at $6.5,which is 15.36% down from its 52 week high and 152.43% up from its 52 week low.

What is Puma Biotechnology, Inc.'s market capitalisation today?

Puma Biotechnology, Inc. market capitalisation is $0.00T as on .

How to invest in Puma Biotechnology, Inc. Stock (PBYI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Puma Biotechnology, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Puma Biotechnology, Inc. Shares that will get you 0.2308 shares as per Puma Biotechnology, Inc. share price of $6.5 per share as on March 25, 2026 at 9:41 pm IST.

What is the minimum amount required to buy Puma Biotechnology, Inc. Stock (PBYI) from India?

Indian investors can start investing in Puma Biotechnology, Inc. (PBYI) shares with as little as ₹94.138 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹941.38 in Puma Biotechnology, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Puma Biotechnology, Inc. share’s latest price of $6.5 as on March 25, 2026 at 9:41 pm IST, you will get 1.5385 shares of Puma Biotechnology, Inc.. Learn more about fractional shares .

What are the returns that Puma Biotechnology, Inc. has given to Indian investors in the last 5 years?

Puma Biotechnology, Inc. stock has given -38.08% share price returns and 28.28% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?